What is the recommended dosing regimen of 20% albumin for a hypotensive patient with hyponatremia, including weight‑based dosing and maximum daily limit?

Albumin Dosing for Hypotensive Patients with Hyponatremia

For a hypotensive patient with hyponatremia, administer 20% albumin at 100 mL (25 g) intravenously at the initiation of treatment, with consideration for higher total doses (>80 g over several days) if the patient has cirrhosis with ascites and baseline serum albumin <30 g/L.

Weight-Based Dosing Recommendations

The FDA-approved dosing varies by clinical context 1:

For Hypovolemic Shock

• Total dose should not exceed 2 g/kg body weight in the absence of active bleeding 1
• The volume and speed of infusion must be adapted to individual patient response 1
• 20% albumin is hyperoncotic and will expand plasma volume by 3-4 times the volume administered by drawing fluid from interstitial spaces 1

For Hypoproteinemia with Hypotension

• Adults: 50-75 g daily 1
• Children: 25 g daily 1
• Rate should not exceed 2 mL/minute in hypoproteinemic patients to avoid circulatory overload and pulmonary edema 1

Specific Context: Cirrhosis with Hyponatremia

If your patient has cirrhosis with ascites and hyponatremia:

• High-dose albumin (>80 g total) is superior to low-dose (≤80 g) for correcting hypervolemic hyponatremia, particularly when baseline albumin is <30 g/L 2
• This approach independently improves both hyponatremia resolution (OR 1.919) and serum albumin levels (OR 3.001) 2
• Hyponatremia resolution is independently associated with improved 30-day survival 3

For Spontaneous Bacterial Peritonitis (if applicable)

• Day 1: 1.5 g/kg body weight
• Day 3: 1.0 g/kg body weight 4
• This regimen reduces acute kidney injury (10% vs 33%) and mortality (10% vs 29%) compared to antibiotics alone 4

Maximum Daily Limits and Safety

No absolute maximum daily limit is specified in FDA labeling, but practical constraints include:

• Total dose should generally not exceed the normal body albumin pool (~2 g/kg) in non-bleeding patients 1
• For a 70 kg patient, this translates to approximately 140 g maximum
• Monitor closely for fluid overload, pulmonary edema, and circulatory embarrassment 1

Critical Safety Considerations

Dehydration status is crucial: If the patient is dehydrated, 20% albumin will worsen hypovolemia by pulling fluid from already depleted interstitial spaces. In this scenario:

• Add crystalloids concurrently, OR
• Use 5% albumin instead 1

Rate of administration matters: In hypoproteinemic patients with normal blood volumes, exceeding 2 mL/min risks circulatory embarrassment 1. However, in true hypovolemic shock, faster rates may be necessary based on hemodynamic response.

Practical Dosing Algorithm

1. Assess volume status first:

   • True hypovolemia (shock) → 20% albumin acceptable, faster rates permitted
   • Euvolemia with hypoproteinemia → 20% albumin at ≤2 mL/min
   • Dehydration → add crystalloids or use 5% albumin

2. Initial dose: 100 mL of 25% albumin (25 g) 5

3. Subsequent dosing based on context:

   • **Cirrhosis with hyponatremia and albumin <30 g/L**: Continue to total >80 g over treatment period 2
   • Hypovolemic shock: Titrate to hemodynamic response, max ~2 g/kg total 1
   • General hypoproteinemia: 50-75 g daily for adults 1

4. Monitor: Hemodynamics, serum sodium, serum albumin, signs of fluid overload

Important Caveats

• Albumin does NOT improve outcomes in infections other than SBP and increases pulmonary edema risk 4
• In intradialytic hypotension with hypoalbuminemia, 100 mL of 25% albumin at dialysis initiation reduces hypotension episodes and improves ultrafiltration 5
• The evidence for albumin in hyponatremia is strongest in cirrhotic patients; extrapolation to other causes of hyponatremia should be done cautiously
• Cost considerations are significant: albumin therapy can exceed $20,000 annually for frequent use 6